GTB-3550
GT Biopharma
[]
 gt biopharma presents preclinical data demonstrating second-generation cd19 targeting tri-specific killer engager (trike) driving robust nk cell function against b cell malignancies at eha 2022 congress
Free Online Press Release Distribution Service For Business